Global Acute Ischemic Stroke Therapeutics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	October, 2022	INF17487983

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	October, 2022
SKU	INF17487983

Global Acute Ischemic Stroke Therapeutics Market 2023-2027

Technavio has been monitoring the acute ischemic stroke therapeutics market and it is poised to grow by $1524.49 mn during 2023-2027, accelerating at a CAGR of 5.72% during the forecast period. Our report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of disease, increasing adoption of NOACs, and increasing prevalence of sedentary lifestyles.

Technavio's acute ischemic stroke therapeutics market is segmented as below:

By Type

Thrombolytics
Anticoagulants
Antiplatelets
Antihypertensives

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the TBI, a value-addition in AIS research as one of the prime reasons driving the acute ischemic stroke therapeutics market growth during the next few years. Also, the advent of genomic medicine and a strong pipeline will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the acute ischemic stroke therapeutics market covers the following areas:

Acute ischemic stroke therapeutics market sizing
Acute ischemic stroke therapeutics market forecast
Acute ischemic stroke therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute ischemic stroke therapeutics market vendors that include Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Medtronic Plc, NoNO Inc., SanBio Co Ltd., Stryker Corp., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson, Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd. Also, the acute ischemic stroke therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Market Segmentation by Distribution Channel
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global acute ischemic stroke therapeutics market 2017- 2021
  - Table Historic market size – Data table on global acute ischemic stroke therapeutics market
- Type Segment Analysis 2017-2021
  - Table Historic market size – Type segment 2017-2021 ($ million)
- Distribution Channel Segment Analysis 2017-2021
  - Table Historic market size – Distribution channel segment 2017-2021 ($ million)
- Geography Segment Analysis 2017-2021
  - Table Historic market size – Geography segment 2017-2021 ($ million)
- Country Segment Analysis 2017-2021
  - Table Historic market size – Country segment 2017-2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2022-2027 (%)
  - Table Data Table on Type - Market share 2022-2027 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Thrombolytics - Market size and forecast 2022-2027
  - Table Chart on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Thrombolytics - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Thrombolytics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Thrombolytics - Year-over-year growth 2022-2027 (%)
- Anticoagulants - Market size and forecast 2022-2027
  - Table Chart on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Anticoagulants - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Anticoagulants - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Anticoagulants - Year-over-year growth 2022-2027 (%)
- Antiplatelets - Market size and forecast 2022-2027
  - Table Chart on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Antiplatelets - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Antiplatelets - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Antiplatelets - Year-over-year growth 2022-2027 (%)
- Antihypertensives - Market size and forecast 2022-2027
  - Table Chart on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
- Other therapeutics - Market size and forecast 2022-2027
  - Table Chart on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ million)
Market Segmentation by Distribution Channel
- Market segments
  - Table Chart on Distribution Channel - Market share 2022-2027 (%)
  - Table Data Table on Distribution Channel - Market share 2022-2027 (%)
- Comparison by Distribution Channel
  - Table Chart on Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacies - Market size and forecast 2022- 2027
  - Table Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
- Retail pharmacies - Market size and forecast 2022-2027
  - Table Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
- Online pharmacies - Market size and forecast 2022-2027
  - Table Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
- Market opportunity by Distribution Channel
  - Table Market opportunity by Distribution Channel ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- UK - Market size and forecast 2022-2027
  - Table Chart on UK - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on UK - Market size and forecast 2022-2027 ($ million)
  - Table Chart on UK - Year-over-year growth 2022-2027 (%)
  - Table Data Table on UK - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Canada - Market size and forecast 2022-2027
  - Table Chart on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Canada - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Rising prevalence of disease
  - Increasing adoption of NOACs
  - Increasing prevalence of sedentary lifestyles
- Market challenges
  - Unmet needs for anticoagulant reversal agents
  - Extensive use of generic products
  - Presence of alternative therapies
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - TBI, a value-addition in AIS research
  - Advent of genomic medicine
  - Strong pipeline
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- Athersys Inc.
  - Table Athersys Inc. - Overview
  - Table Athersys Inc. - Product / Service
  - Table Athersys Inc. - Key offerings
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Biogen Inc.
  - Table Biogen Inc. - Overview
  - Table Biogen Inc. - Product / Service
  - Table Biogen Inc. - Key offerings
- Boehringer Ingelheim International GmbH
  - Table Boehringer Ingelheim International GmbH - Overview
  - Table Boehringer Ingelheim International GmbH - Business segments
  - Table Boehringer Ingelheim International GmbH - Key news
  - Table Boehringer Ingelheim International GmbH - Key offerings
  - Table Boehringer Ingelheim International GmbH - Segment focus
- Bristol Myers Squibb Co.
  - Table Bristol Myers Squibb Co. - Overview
  - Table Bristol Myers Squibb Co. - Product / Service
  - Table Bristol Myers Squibb Co. - Key offerings
- Daiichi Sankyo Co. Ltd.
  - Table Daiichi Sankyo Co. Ltd. - Overview
  - Table Daiichi Sankyo Co. Ltd. - Business segments
  - Table Daiichi Sankyo Co. Ltd. - Key news
  - Table Daiichi Sankyo Co. Ltd. - Key offerings
  - Table Daiichi Sankyo Co. Ltd. - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Johnson and Johnson
  - Table Johnson and Johnson - Overview
  - Table Johnson and Johnson - Business segments
  - Table Johnson and Johnson - Key news
  - Table Johnson and Johnson - Key offerings
  - Table Johnson and Johnson - Segment focus
- Medtronic Plc
  - Table Medtronic Plc - Overview
  - Table Medtronic Plc - Business segments
  - Table Medtronic Plc - Key news
  - Table Medtronic Plc - Key offerings
  - Table Medtronic Plc - Segment focus
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Sanofi SA
  - Table Sanofi SA - Overview
  - Table Sanofi SA - Business segments
  - Table Sanofi SA - Key news
  - Table Sanofi SA - Key offerings
  - Table Sanofi SA - Segment focus
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations